-
www.ahrq.gov/sites/default/files/wysiwyg/research/publications/pubcomguide/PSA-Video-Script-Sample.doc
June 02, 2025 - Narrator V/O:
PSA DISCOVERY HEALTH & AHRQ
“Understanding Your Prescription” –
· :30 Version 2
Narrator: Unknown (Discovery employee)
Talent: Dr. Carolyn Clancy
Video/Graphics
Audio
1.
Animated Discovery Health & AHRQ Logo
Narrator V/O:
This message is from Discovery Health Channel and the U.S. Agency…
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/injuries/fallspx/manapb22.html
December 01, 2017 - The Falls Management Program: A Quality Improvement Initiative for Nursing Facilities
Appendix B22: Suggestions for Further Assessment and/or Interventions
Previous Page Next Page
Table of Contents
The Falls Management Program: A Quality Improvement Initiative for Nursing Facilities
Chapter 1. Int…
-
www.ahrq.gov/cahps/about-cahps/principles/index.html
January 01, 2020 - Principles Underlying CAHPS Surveys
In 1999, the CAHPS Consortium articulated a set of design principles that guided its work on the development of surveys and accompanying report formats. 1 Over time, those principles have been refined to reflect the expansion of surveys and uses beyond public reporting to in…
-
psnet.ahrq.gov/node/865878/psn-pdf
May 15, 2024 - Testing an intervention to improve health care worker
well-being during the COVID-19 pandemic: a cluster
randomized clinical trial.
May 15, 2024
Meredith LS, Ahluwalia SC, Chen PG, et al. Testing an intervention to improve health care worker well-
being during the COVID-19 pandemic: a cluster randomized clinical t…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
October 08, 2025 - RCTs
Table G-1. Quality assessments of included randomized controlled trials
Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …
-
psnet.ahrq.gov/node/37695/psn-pdf
April 11, 2011 - Development, testing, and findings of a pediatric-focused
trigger tool to identify medication-related harm in US
children's hospitals.
April 11, 2011
Takata GS, Mason W, Taketomo C, et al. Development, testing, and findings of a pediatric-focused trigger
tool to identify medication-related harm in US children's ho…
-
digital.ahrq.gov/funding-mechanism/developing-new-clinical-decision-support-disseminate-and-implement-evidence-based
January 01, 2023 - Developing New Clinical Decision Support to Disseminate and Implement Evidence-Based Research Findings (R18)
Scalable Decision Support and Shared Decision Making for Lung Cancer Screening
Description
Researchers successfully developed Decision Precision+, a shared decision mak…
-
psnet.ahrq.gov/node/61114/psn-pdf
November 11, 2020 - A mixed-methods analysis of patient safety incidents
involving opioid substitution treatment with methadone or
buprenorphine in community-based care in England and
Wales.
November 11, 2020
Gibson R, MacLeod N, Donaldson LJ, et al. A mixed?methods analysis of patient safety incidents involving
opioid substitution …
-
psnet.ahrq.gov/node/866274/psn-pdf
July 10, 2024 - From the randomized AMBORA trial to clinical practice:
comparison of medication errors in oral antitumor
therapy.
July 10, 2024
Cuba L, Dürr P, Dörje F, et al. From the randomized AMBORA trial to clinical practice: comparison of
medication errors in oral antitumor therapy. Clin Pharmacol Ther. 2024;116(1):194-203.…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
July 13, 2011 - depressive disorders, do second-generation antidepressants differ in efficacy or
effectiveness in treating … responded to one agent in the past, is that agent better than
current pharmacologic alternatives at treating … medications
(including a tricyclic in combination) differ in their efficacy or effectiveness for
treating … the depressive episode or for treating the accompanying symptom? … addresses the
second generation antidepressant pharmacologic options available to clinicians for
treating
-
psnet.ahrq.gov/node/44805/psn-pdf
January 27, 2016 - saving-lives-and-saving-money-hospital-acquired-conditions-update
https://psnet.ahrq.gov/issue/wound-care-teams-preventing-and-treating-pressure-ulcers
-
psnet.ahrq.gov/node/45743/psn-pdf
June 21, 2017 - Nearly one-quarter of the changes were classified as
emergent, requiring immediate notification to a treating
-
psnet.ahrq.gov/node/45438/psn-pdf
September 07, 2016 - In many cases, vital signs were not monitored
as specified by treating physicians.
-
psnet.ahrq.gov/node/43516/psn-pdf
June 15, 2017 - employed failure mode and effect analysis methodology to detect potential
problems in the process of treating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-urinary-retention_disposition-comments.pdf
September 15, 2014 - Report is helpful because clinically, we have been treating CUR
based on “what was always done”. … This report has value
because it highlights the little evidence we have for treating
symtpomatic CUR … We found no data to assess the impact of treating CUR
independent of treating benign prostatic enlargement … We found no data to assess the impact of treating CUR
independent of treating benign prostatic enlargement … However we found no studies of drugs used in
treating CUR in men with BPH and no studies of treating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-decision-modeling.ppt
June 01, 2012 - Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (1 of 8)
Trikalinos … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (3 of 8)
AChE-I = … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (6 of 8)
Step 3 is … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (7 of 8)
Step 4 in … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (8 of 8)
The fifth
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-decision-modeling.ppt
June 01, 2012 - Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (1 of 8)
Trikalinos … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (3 of 8)
AChE-I = … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (6 of 8)
Step 3 is … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (7 of 8)
Step 4 in … Illustrative Example: Positron Emission Tomography in Treating Alzheimer’s Disease (8 of 8)
The fifth
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0094_04-09-2009.pdf
January 01, 2009 - interest from the second nominator include combined treatments,
effectiveness of early interventions, treating … Treating commonly associated medical conditions in ASD
a.
-
integrationacademy.ahrq.gov/print/pdf/node/23266
May require fee or membership
Description
Member organization for family physicians with the goal of treating
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Ultra-rapid acting inhaled insulin (Technosphere insulin inhalation system with Afrezza)
for treating … Treating and managing diabetes to prevent complications require patients to make a lifelong
commitment … This led to the reframing of bariatric surgery as
metabolic surgery for treating refractory T2DM in … One such injected
agent is ranibizumab (Lucentis®), which FDA approved in 2012 for treating DME; it … (Alpharetta,
GA).111 In September 2014, FDA approved Iluvien for treating DME in patients “who have